2019
Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency Through Suppression of Erythroid Heme Synthesis
Publication
Publication
Hepatology , Volume 70 - Issue 1 p. 434- 436
Delta-aminolevulinic acid dehydratase-porphyria (ADP) is an autosomal recessive disorder of heme biosynthesis, caused by delta-aminolevulinic acid dehydratase deficiency (ALAD).(1) We report an important change in pathophysiological concepts and subsequent therapeutic options for patients with ADP, based on a review of previous cases and the treatment effects in a reported case.
| Additional Metadata | |
|---|---|
| doi.org/10.1002/hep.30543, hdl.handle.net/1765/118224 | |
| Hepatology | |
| Organisation | Department of Internal Medicine |
|
Neeleman, R.A., van Beers, E., Friesema, E., Koole-Lesuis, R., van der Pol, W.-L., Wilson, P., & Langendonk, J. (2019). Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency Through Suppression of Erythroid Heme Synthesis. Hepatology, 70(1), 434–436. doi:10.1002/hep.30543 |
|
